-
1
-
-
4444382796
-
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
-
DOI 10.1016/S0140-6736(04)17018-9, PII S0140673604170189
-
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952 (Pubitemid 39208455)
-
(2004)
Lancet
, vol.364
, Issue.9438
, pp. 937-952
-
-
Yusuf, P.S.1
Hawken, S.2
Ounpuu, S.3
Dans, T.4
Avezum, A.5
Lanas, F.6
McQueen, M.7
Budaj, A.8
Pais, P.9
Varigos, J.10
Lisheng, L.11
-
2
-
-
0033120980
-
Age at natural menopause and total mortality and mortality from ischemic heart disease: The Adventist health study
-
DOI 10.1016/S0895-4356(98)00170-X, PII S089543569800170X
-
Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist health study. J Clin Epidemiol 1999;52:303-307 (Pubitemid 29305302)
-
(1999)
Journal of Clinical Epidemiology
, vol.52
, Issue.4
, pp. 303-307
-
-
Jacobsen, B.K.1
Knutsen, S.F.2
Fraser, G.E.3
-
3
-
-
29244454020
-
The association between early menopause and risk of ischaemic heart disease: Influence of Hormone Therapy
-
DOI 10.1016/j.maturitas.2005.04.009, PII S0378512205000848
-
Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 2006;53:226-233 (Pubitemid 41820516)
-
(2006)
Maturitas
, vol.53
, Issue.2
, pp. 226-233
-
-
Lokkegaard, E.1
Jovanovic, Z.2
Heitmann, B.L.3
Keiding, N.4
Ottesen, B.5
Pedersen, A.T.6
-
4
-
-
34247177716
-
Menopausal hormone therapy
-
Wenger NK, Collins Peds. London: Taylor & Francis
-
Stevenson JC. Menopausal hormone therapy. In: Wenger NK, Collins Peds. Women & Heart Disease. London: Taylor & Francis, 2005:375-379
-
(2005)
Women & Heart Disease
, pp. 375-379
-
-
Stevenson, J.C.1
-
5
-
-
34948846041
-
Postmenopausal hormone therapy in clinical perspective
-
DOI 10.1097/gme.0b013e31802e8508
-
Hodis HN, Mack WJ. Postmenopausal hormone therapy in clinical perspective. Menopause 2007;14:1-14 (Pubitemid 47517597)
-
(2007)
Menopause
, vol.14
, Issue.5
, pp. 944-957
-
-
Hodis, H.N.1
Mack, W.J.2
-
6
-
-
34247136661
-
HRT and the primary prevention of cardiovascular disease
-
DOI 10.1016/j.maturitas.2007.02.007, PII S0378512207000680
-
Stevenson JC. HRT and the primary prevention of cardiovascular disease. Maturitas 2007;57:31-34 (Pubitemid 46602887)
-
(2007)
Maturitas
, vol.57
, Issue.1
, pp. 31-34
-
-
Stevenson, J.C.1
-
7
-
-
34250696907
-
Estrogen therapy and coronary-artery calcification
-
DOI 10.1056/NEJMoa071513
-
Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary artery calcification. NEJM 2007;356:2591-2602 (Pubitemid 46961004)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.25
, pp. 2591-2602
-
-
Manson, J.E.1
Allison, M.A.2
Rossouw, J.E.3
Carr, J.J.4
Langer, R.D.5
Hsia, J.6
Kuller, L.H.7
Cochrane, B.B.8
Hunt, J.R.9
Ludlam, S.E.10
Pettinger, M.B.11
Gass, M.12
Margolis, K.L.13
Nathan, L.14
Ockene, J.K.15
Prentice, R.L.16
Robbins, J.17
Stefanick, M.L.18
-
8
-
-
34047237367
-
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
-
DOI 10.1001/jama.297.13.1465
-
Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and time since menopause. JAMA 2007;297:1465-1477 (Pubitemid 46556472)
-
(2007)
Journal of the American Medical Association
, vol.297
, Issue.13
, pp. 1465-1477
-
-
Rossouw, J.E.1
Prentice, R.L.2
Manson, J.E.3
Wu, L.4
Barad, D.5
Barnabei, V.M.6
Ko, M.7
Lacroix, A.Z.8
Margolis, K.L.9
Stefanick, M.L.10
-
9
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women
-
Writing Group for the Women's Health Initiative Investigators
-
Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-333
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
-
10
-
-
33748794528
-
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study
-
DOI 10.1093/eurheartj/ehl183
-
Collins P, Flather M, Lees B, Mister R, Proudler AJ, Stevenson JC. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP pilot study. Eur Heart J 2006;27:2046-2053 (Pubitemid 44412809)
-
(2006)
European Heart Journal
, vol.27
, Issue.17
, pp. 2046-2053
-
-
Collins, P.1
Flather, M.2
Lees, B.3
Mister, R.4
Proudler, A.J.5
Stevenson, J.C.6
-
11
-
-
33745808844
-
International Consensus Group on HRT and Regulatory Issues. HRT, osteoporosis and regulatory authorities: Quis custodiet ipsos custodes?
-
on behalf of the
-
Stevenson JC on behalf of the International Consensus Group on HRT and Regulatory Issues. HRT, osteoporosis and regulatory authorities: Quis custodiet ipsos custodes? Hum Reprod 2006;21:1668-1671
-
(2006)
Hum Reprod
, vol.21
, pp. 1668-1671
-
-
Stevenson, J.C.1
|